Therefore, it is conceivable that quercetin attenuates cardiac hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 (c-fos, c-jun) activity, thereby causing a decrease in the transcription of the downstream hypertrophy genes BNP and ANP. The gene discussed is NPPB; the disease is cardiac hypertrophy.